Any stock, in context
ZYDUSLIFE · Healthcare
Zydus Lifesciences Ltd.
Observation · 15 Oct 2026
How these are readZydus Lifesciences closed at ₹1,140.2 on 15 Oct 2026, 11.9% above its 200-day average and 0.4% below its 50-day average: above the long line, below the short one. It sits 6.2% below its highest close of the past year, in the fourth fifth of its one-year range. Over three months it fell 0.2%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +11.9%
- the long line
- vs 50-day
- −0.4%
- the short line
- From 52w high
- −6.2%
- ₹835.5₹1,232.1
- 3 months
- −0.2%
- sector median −2.7% · 65 of 146
Nifty Next 50 · Healthcare · EQ series · median traded value ₹127 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- +1.38%
- 1W
- –
- 1M
- +3.75%
- 3M
- −0.22%
- YTD
- –
- 1Y
- +16.77%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.